comparemela.com
Home
Live Updates
Eurofins Discovery: Use of BioMAP Platform to Assess Nutrace
Eurofins Discovery: Use of BioMAP Platform to Assess Nutrace
Eurofins Discovery: Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central
ST. CHARLES, Mo., June 23, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery
Related Keywords
Claude Huriez ,
Sibelius Ltd ,
University Of Buckingham ,
Bioscience Research ,
Phenotypic Center ,
Nuclear Hormone Receptors ,
Institute For Biomedical ,
Euronext Paris Stock Exchange ,
European Genomic Institute For Diabetes ,
Phenotypic Profiling ,
Screening Platform ,
European Genomic Institute ,
Hospital Claude Huriez ,
Eurofins Discovery ,
Ion Channels ,
Euronext Paris Stock ,
Eurofins ,
Discovery ,
Iomap ,
Platform ,
Ssess ,
Nutraceuticals ,
Published ,
Abiomed ,
Central ,